Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001104659-19-049141

Options or other derivatives

  • Chief Commercial Officer acquired 125,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Marek David C · Chief Commercial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-09-04 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +125,000 125,000 D
Loading xslF345X03/a4.xml…